fundvisualizer.com

Morgan Stanley Inst Global Franchise AMSFBX

Performance (before sales charge)

As of 02/28/2023

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 09/30/2022
Stock
75.49%
Non-U.S. Stock
22.67%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
1.84%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 09/30/2022

Basic materials

0.00%

Consumer cyclical

3.82%

Financial services

10.81%

Real estate

0.00%

Consumer defensive

26.05%

Health care

23.20%

Utilities

0.00%

Communication services

2.35%

Energy

0.00%

Industrials

9.97%

Technology

21.96%

Top 10 holdings

As of 09/30/2022

Microsoft Corp
9.09%
Philip Morris International Inc
6.91%
Reckitt Benckiser Group PLC
6.14%
Visa Inc Class A
5.93%
Danaher Corp
5.83%
Accenture PLC Class A
4.92%
Thermo Fisher Scientific Inc
4.72%
SAP SE
4.48%
Intercontinental Exchange Inc
3.87%
Abbott Laboratories
3.81%
Fund assets

$3.01 Billion

Share class

A

Morningstar category

Global Large-Stock Blend

Expense ratio

1.16%

Investment objective

World Stock

Documents